pnd3hjf

Property	Value
?:abstract	Acquired immunodeficiency syndrome (AIDS) complicated with tuberculosis (TB) is a global public issue. Due to the paucity of bacteria in AIDS/TB, blood-based biomarkers that reflect disease severity are desired. Plasma levels of matricellular proteins, such as osteopontin (OPN) and galectin-9 (Gal-9), are known to be elevated in AIDS and TB. Therefore, full-length (FL)-Gal9 and FL-OPN, and their truncated forms (Tr-Gal9, Ud-OPN), and 38 cytokines/chemokines were measured in the plasma of 24 AIDS (other than TB), 49 TB, and 33 AIDS/TB patients. Receiver-operating characteristic analysis was used to screen molecules that could distinguish either between disease and normal group, among each disease group, or between deceased patients and survivors. Selected molecules were further analyzed for significant differences. Tr-Gal9 had the highest ability to differentiate TB from AIDS or AIDS/TB, while Ud-OPN distinguished multidrug resistance (MDR)-TB from non-MDR TB, and extra-pulmonary TB from pulmonary TB. Molecules significantly elevated in deceased patients included; FL-Gal9, Tr-Gal9, interleukin (IL)-1 receptor antagonist, IL-17A and transforming growth factor-α in AIDS; IL-6, granulocyte colony-stimulating factor and monocyte chemotactic protein-1 in TB; and macrophage inflammatory protein-1β in AIDS/TB. From the sensitivity, specificity, and significant elevation, Tr-Gal9 is the best biomarker of inflammation and severity in AIDS and AIDS/TB.
is ?:annotates of	<https://research.tib.eu/covid-19/entity/2pnd3hjf_hasAnnotation_C0020517> <https://research.tib.eu/covid-19/entity/2pnd3hjf_hasAnnotation_C0021368> <https://research.tib.eu/covid-19/entity/2pnd3hjf_hasAnnotation_C1416402>
?:creator	<https://research.tib.eu/covid-19/entity/Padilla%2C_Shirley_T.%3B_Niki%2C_Toshiro%3B_Furushima%2C_Daisuke%3B_Bai%2C_Gaowa%3B_Chagan-Yasutan%2C_Haorile%3B_Telan%2C_Elizabeth_Freda%3B_Tactacan-Abrenica%2C_Rosario_Jessica%3B_Maeda%2C_Yosuke%3B_Solante%2C_Rontgene%3B_Hattori%2C_Toshio>
?:doi	10.3390/biom10111495
?:doi	<https://research.tib.eu/covid-19/entity/10.3390/biom10111495>
?:journal	Biomolecules
?:license	cc-by
?:pdf_json_files	document_parses/pdf_json/9332741b6ec84a381d6075d778d815a72b5c2cc8.json
?:pmc_json_files	document_parses/pmc_json/PMC7693693.xml.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7693693>
?:pmid	<https://research.tib.eu/covid-19/entity/33143141.0>
?:pmid	33143141.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/2pnd3hjf_HAS_C0001175_COMPLICATES_C0041296> <https://research.tib.eu/covid-19/entity/2pnd3hjf_HAS_C0020517_COEXISTS_WITH_C0001175> <https://research.tib.eu/covid-19/entity/2pnd3hjf_HAS_C0020517_COEXISTS_WITH_C0041296> <https://research.tib.eu/covid-19/entity/2pnd3hjf_HAS_C0020517_PREDISPOSES_C0001175> <https://research.tib.eu/covid-19/entity/2pnd3hjf_HAS_C0020517_PREDISPOSES_C0275524> <https://research.tib.eu/covid-19/entity/2pnd3hjf_HAS_C0021760_ASSOCIATED_WITH_C0041296> <https://research.tib.eu/covid-19/entity/2pnd3hjf_HAS_C0040688_ASSOCIATED_WITH_C0001175> <https://research.tib.eu/covid-19/entity/2pnd3hjf_HAS_C0069676_ASSOCIATED_WITH_C0001175> <https://research.tib.eu/covid-19/entity/2pnd3hjf_HAS_C0069676_ASSOCIATED_WITH_C0041296> <https://research.tib.eu/covid-19/entity/2pnd3hjf_HAS_C0079459_ASSOCIATED_WITH_C0041296> <https://research.tib.eu/covid-19/entity/2pnd3hjf_HAS_C0128897_ASSOCIATED_WITH_C0041296> <https://research.tib.eu/covid-19/entity/2pnd3hjf_HAS_C0209338_ASSOCIATED_WITH_C0041296> <https://research.tib.eu/covid-19/entity/2pnd3hjf_HAS_C0537111_ASSOCIATED_WITH_C0001175> <https://research.tib.eu/covid-19/entity/2pnd3hjf_HAS_C0537111_ASSOCIATED_WITH_C0041296> <https://research.tib.eu/covid-19/entity/2pnd3hjf_HAS_C0537111_PREDISPOSES_C0021368> <https://research.tib.eu/covid-19/entity/2pnd3hjf_HAS_C1416402_ASSOCIATED_WITH_C0001175> <https://research.tib.eu/covid-19/entity/2pnd3hjf_HAS_C1701790_ASSOCIATED_WITH_C0001175>
?:sha_id	<https://research.tib.eu/covid-19/entity/9332741b6ec84a381d6075d778d815a72b5c2cc8>
?:source	Medline; PMC
?:title	Plasma Levels of a Cleaved Form of Galectin-9 Are the Most Sensitive Biomarkers of Acquired Immune Deficiency Syndrome and Tuberculosis Coinfection
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-10-30

Property

Value

?:abstract

Acquired immunodeficiency syndrome (AIDS) complicated with tuberculosis (TB) is a global public issue. Due to the paucity of bacteria in AIDS/TB, blood-based biomarkers that reflect disease severity are desired. Plasma levels of matricellular proteins, such as osteopontin (OPN) and galectin-9 (Gal-9), are known to be elevated in AIDS and TB. Therefore, full-length (FL)-Gal9 and FL-OPN, and their truncated forms (Tr-Gal9, Ud-OPN), and 38 cytokines/chemokines were measured in the plasma of 24 AIDS (other than TB), 49 TB, and 33 AIDS/TB patients. Receiver-operating characteristic analysis was used to screen molecules that could distinguish either between disease and normal group, among each disease group, or between deceased patients and survivors. Selected molecules were further analyzed for significant differences. Tr-Gal9 had the highest ability to differentiate TB from AIDS or AIDS/TB, while Ud-OPN distinguished multidrug resistance (MDR)-TB from non-MDR TB, and extra-pulmonary TB from pulmonary TB. Molecules significantly elevated in deceased patients included; FL-Gal9, Tr-Gal9, interleukin (IL)-1 receptor antagonist, IL-17A and transforming growth factor-α in AIDS; IL-6, granulocyte colony-stimulating factor and monocyte chemotactic protein-1 in TB; and macrophage inflammatory protein-1β in AIDS/TB. From the sensitivity, specificity, and significant elevation, Tr-Gal9 is the best biomarker of inflammation and severity in AIDS and AIDS/TB.

is ?:annotates of